Moolec Science SA (MLEC) vs Matinas Biopharma (MTNB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Moolec Science SA is the larger company by market cap ($3.0 million vs $2.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLEC | MTNB |
|---|---|---|
| Share price | $4.19 | $2.83 |
| Market cap | $3.04M | $2.77M |
| 1-day change | -12.89% | +2.17% |
| EPS (TTM) | $-199.02 | $-17.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.22 | $28.95 |
| 52-week low | $3.08 | $2.27 |
| Distance from 52-week high | -81.96% | -90.22% |
| Average volume | 17.09K | 408.10K |
| Shares outstanding | 726.12K | 979.52K |
| Employees | — | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Moolec Science SA
MLEC stock →Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Healthcare · Biotechnology
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
MLEC vs MTNB FAQ
Which is bigger, Moolec Science SA or Matinas Biopharma?
Moolec Science SA (MLEC) is larger, with a market capitalization of $3.04M compared with $2.77M for Matinas Biopharma (MTNB).
Are Moolec Science SA and Matinas Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.